Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To investigate the association between the the early administration of L-Arginine after CPB-assisted cardiac surgery and the incidence of CS-AKI in adult patients. To test if it can reduce the incidence of post-operative AKI.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Arginine Use | At least one dose of L-arginie was administered in the early postoperative stage |
| |
| Without Arginine | No L-arginie was administered |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| L-Arginine hydrochloride | Drug | Postoperative administration of L-Arginine hydrochloride before incidence of CS-AKI |
|
| Measure | Description | Time Frame |
|---|---|---|
| incidence of postoperative AKI | Serum Creatinine Criteria: Increase in Serum Creatinine: An absolute increase in serum creatinine of 0.3 mg/dL (26.5 µmol/L) within 48 hours. OR a percentage increase in serum creatinine of ≥50% within 7 days. These criteria are relative to the baseline creatinine level, which is usually the recent preadmission value. Urine Output Criteria: Oliguria, defined as a urine output <0.5 mL/kg/h for more than 6 hours. OR anuria, defined as a urine output <100 mL in 24 hours. | from the time of end of surgery until time of documented hospital discharge or time of death, whichever came first, assessed up to 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| Renal failure | KDIGO defined AKI stage ≥ 2, or if dialysis is required for newly developed conditions KDIGO classifies AKI into three stages based on the severity: Stage 2: Increase in serum creatinine of 2.0 to 2.9 times baseline OR Urine output <0.5 mL/kg/h for ≥12 hours. Stage 3: Increase in serum creatinine of 3.0 times baseline OR Increase in serum creatinine to ≥4.0 mg/dL OR Initiation of renal replacement therapy (RRT) OR Urine output <0.3 mL/kg/h for ≥24 hours OR anuria for ≥12 hours. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All patients who were admitted to the ICU after cardiac surgery with CPB.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ziyu Zheng | Contact | +86-13228082320 | zhengziyu@126.com |
| Name | Affiliation | Role |
|---|---|---|
| Chong Lei | Xijing Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Xijing Hospital | Recruiting | Xi'an | Shaanxi | 710032 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D058186 | Acute Kidney Injury |
| ID | Term |
|---|---|
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| from the time of end of surgery until time of documented hospital discharge or time of death, whichever came first, assessed up to 30 days |
| in-hospital mortality | all-cause postoperative deaths observed | from the time of end of surgery until time of documented hospital discharge or time of death, whichever came first, assessed up to 30 days |
| length of in-hospital stay | postoperative stay until discharge or death | from the time of end of surgery until time of documented hospital discharge or time of death, whichever came first, assessed up to 30 days |
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |